N@N

John Ransom Upgraded (THC) to Strong Buy and Increased Target to $120 on, Jan 20th, 2022

John Ransom of Raymond James, Upgraded "Tenet Healthcare Corporation" (THC) to Strong Buy and Increased Target from $105 to $120 on, Jan 20th, 2022.

John has made no other calls on THC in the last 4 months.

There are 7 other peers that have a rating on THC. Out of the 7 peers that are also analyzing THC, 3 agree with John's Rating of Hold. Following are those relevant analyst calls for the last 4 months

---

• Whit Mayo of "SVB Leerink" Maintained at Hold with Increased Target to $88 on, Friday, January 7th, 2022
• David Macdonald of "Truist Securities" Maintained at Hold with Increased Target to $90 on, Wednesday, January 5th, 2022
• Scott Fidel of "Stephens & Co." Maintained at Hold with Increased Target to $92 on, Tuesday, November 9th, 2021

These are the ratings of the 4 analyists that currently disagree with John

---

• Sarah James of "Barclays" Maintained at Buy with Increased Target to $87 on, Tuesday, December 21st, 2021
• Ann Hynes of "Mizuho" Maintained at Strong Buy with Increased Target to $90 on, Wednesday, November 10th, 2021
• Jason Cassorla of "Citigroup" Maintained at Strong Buy with Increased Target to $91 on, Monday, October 25th, 2021
• Jonathan Yong of "Credit Suisse" Maintained at Buy with Increased Target to $95 on, Friday, October 22nd, 2021

Contributing Sources

---